BioTelemetry (BEAT) Tops Q3 EPS by 2c

BioTelemetry (NASDAQ: BEAT) reported Q3 EPS of $0.13, $0.02 better than the analyst estimate of $0.11. Revenue for the quarter came in at $43.5 million versus the consensus estimate of $46.05 million.

For earnings history and earnings-related data on BioTelemetry (BEAT) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Citi upgrades C.H. Robinson to Buy with $185 target, Opens 90-Day upside catalyst watch
• Evercore ISI on Jersey Mike's Subs (JMKE): 'Anticipating a positive outlook'